The expression of linc00152 is also positively related to tumor invasion, lymph node metastasis, and cancer progression (according to the tumor–node–metastasis [TNM] stage).29 Linc00152 also induces glycolysis, which is a key feature of gastric cancer, by inhibiting miR‐139‐5p, to control the production of the AMP‐activated, alpha 1 catalytic subunit.34, 38. Here, CYTOR is linked to cancer.